Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti COVID-19 Convalescent Plasma Therapy

NCT04345679 is registered in ClinicalTrials.gov with Orthosera Kft. as lead sponsor.

NCT NCT04345679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04345679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti COVID-19 Convalescent Plasma Therapy
Lead sponsor
Orthosera Kft.
Phase
Phase 1
Overall status
Unknown status
Start date
April 14, 2020
Completion date
September 1, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19